One of the first reported Tau tracers is [18F]-FDDNP, which has demonstrated valuable performances in AD monitoring, albeit showing a poor ability to differentiate aggregates of Tau from Aβ-related ones [106]. The gene discussed is MAPT; the disease is Alzheimer disease.